[HTML][HTML] Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease—From Early Cancer Detection to Individualized Cancer Treatment
P David, A Mittelstädt, D Kouhestani, A Anthuber… - Cancers, 2023 - mdpi.com
Simple Summary Gastrointestinal (GI) cancers are a common cancer, affecting both men
and women, normally diagnosed through tissue biopsies in combination with imaging …
and women, normally diagnosed through tissue biopsies in combination with imaging …
[HTML][HTML] EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
L Kocheise, M Schoenlein, B Behrends, V Joerg… - Scientific Reports, 2023 - nature.com
Hepatocellular carcinoma (HCC) has high recurrence rates exceeding 50% despite curative
resection. The serum biomarker alpha-fetoprotein (AFP) is a well-known prognostic marker …
resection. The serum biomarker alpha-fetoprotein (AFP) is a well-known prognostic marker …
DNA methylation markers in esophageal cancer
Y Xu, Z Wang, B Pei, J Wang, Y Xue, G Zhao - Frontiers in Genetics, 2024 - frontiersin.org
Background Esophageal cancer (EC) is a prevalent malignancy characterized by a low 5-
year survival rate, primarily attributed to delayed diagnosis and limited therapeutic options …
year survival rate, primarily attributed to delayed diagnosis and limited therapeutic options …
E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma
Background E2F target genes are essential for the cell cycle. A score that quantifies its
activity is expected to reflect the aggressiveness and prognosis of hepatocellular carcinoma …
activity is expected to reflect the aggressiveness and prognosis of hepatocellular carcinoma …
[HTML][HTML] Comprehensive analysis reveals dual biological function roles of EpCAM in kidney renal clear cell carcinoma
M Chen, Y Gao, H Cao, Z Wang, S Zhang - Heliyon, 2024 - cell.com
Background Epithelial cell adhesion molecule (EpCAM), a well-established marker for
circulating tumor cells, plays a crucial role in the complex process of cancer metastasis. The …
circulating tumor cells, plays a crucial role in the complex process of cancer metastasis. The …
[HTML][HTML] Targeting circulating tumor cells to prevent metastases
K Gostomczyk, MDM Marsool, H Tayyab, A Pandey… - Human Cell, 2024 - Springer
Circulating tumor cells (CTCs) are cancer cells that detach from the primary tumor, enter the
bloodstream or body fluids, and spread to other body parts, leading to metastasis. Their …
bloodstream or body fluids, and spread to other body parts, leading to metastasis. Their …
工程化外泌体在肝癌治疗中的研究进展
赵飞， 李刚 - 肝胆胰外科杂志, 2023 - gdy.qk.wmu.edu.cn
肝癌起病隐匿, 易复发转移, 是全球恶性程度最高的肿瘤之一. 外泌体是含有RNA,
蛋白质和脂质的纳米级细胞囊泡, 由于具有免疫原性低, 可改造性强等独特优势, 近年来 …
蛋白质和脂质的纳米级细胞囊泡, 由于具有免疫原性低, 可改造性强等独特优势, 近年来 …
循环肿瘤细胞在肝细胞癌中的临床综合应用进展
欧伟森， 刘高敏， 徐继威 - 肝胆胰外科杂志, 2023 - gdy.qk.wmu.edu.cn
临床研究上出现了以循环肿瘤细胞(CTC) 为首的“液体活检”(liquid biopsy),
为肿瘤早期诊断和疗效评价等提供了珍贵的参考价值. 肝细胞癌(HCC)“液体活检” …
为肿瘤早期诊断和疗效评价等提供了珍贵的参考价值. 肝细胞癌(HCC)“液体活检” …
[PDF][PDF] Current Applications of Liquid Biopsy in Gastrointestinal Cancer Disease—From Early Cancer Detection to Individualized Cancer Treatment. Cancers 2023, 15 …
P David, A Mittelstädt, D Kouhestani, A Anthuber… - 2023 - researchgate.net
Worldwide, gastrointestinal (GI) cancers account for a significant amount of cancer-related
mortality. Tests that allow an early diagnosis could lead to an improvement in patient …
mortality. Tests that allow an early diagnosis could lead to an improvement in patient …
Biopsia líquida basada en detección y caracterización de células epiteliales circulantes para la intercepción del carcinoma hepatocelular
A Roa Colomo - 2024 - digibug.ugr.es
Introducción y motivación de la tesis: El carcinoma hepatocelular (CHC) es el sexto cáncer
más frecuente y la tercera causa de muerte por cáncer en el mundo. La falta de …
más frecuente y la tercera causa de muerte por cáncer en el mundo. La falta de …